| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |